Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules / Bolzoni, Marina; Storti, Paola; Bonomini, S; Todoerti, K; Guasco, D; Toscani, Denise; Agnelli, L; Neri, A; Rizzoli, V; Giuliani, Nicola. - In: EXPERIMENTAL HEMATOLOGY. - ISSN 0301-472X. - 41:(2013), pp. 387-397. [10.1016/j.exphem.2012.11.005]

Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules

BOLZONI, Marina;STORTI, Paola;TOSCANI, Denise;GIULIANI, Nicola
2013-01-01

2013
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules / Bolzoni, Marina; Storti, Paola; Bonomini, S; Todoerti, K; Guasco, D; Toscani, Denise; Agnelli, L; Neri, A; Rizzoli, V; Giuliani, Nicola. - In: EXPERIMENTAL HEMATOLOGY. - ISSN 0301-472X. - 41:(2013), pp. 387-397. [10.1016/j.exphem.2012.11.005]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2579847
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 58
social impact